Long-term safety of biologics in the treatment of psoriasis
Manisha R Panchal,1 Helen Coope,2 D John McKenna,3 Anton B Alexandroff31Department of Dermatology, Sherwood Forest Hospitals, Kingsmill Hospital, Nottinghamshire, 2Novartis Pharmaceuticals UK Ltd, West Sussex, 3Department of Dermatology, University Hospitals of Leicester, Leicester Royal Infirmary,...
Guardado en:
Autores principales: | Panchal MR, Coope H, McKenna DJ, Alexandroff AB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/915403ad75d74db098f739bee5395718 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
por: Farahnik B, et al.
Publicado: (2016) -
Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability
por: Rogalski C
Publicado: (2015) -
Biologics in the treatment of psoriasis and emerging new therapies in the pipeline
por: Levy LL, et al.
Publicado: (2012) -
Emerging treatment options for psoriasis
por: Taheri A, et al.
Publicado: (2014) -
Biomarkers in the pathogenesis, diagnosis, and treatment of psoriasis
por: Molteni S, et al.
Publicado: (2012)